The prevalence of spike-protein antibodies following at least 3 COVID-19 vaccine doses in immunocompromised individuals
*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide ...